Zymosan A
Zymosan A (Zymosan A from Saccharomyces cerevisiae) is a TLR2 agonist, that targeting TLRs can prevent and suppress IR-induced intestinal injury. Zymosan A exhibits a significant radioprotective effect, and protects IR-induced intestinal injury in mice. Zymosan A promotes the regeneration of intestinal stem cells (ISCs), after IR injury[1].
Product Specifications
CAS Number
58856-93-2
Product Name Alternative
Zymosan A from Saccharomyces cerevisiae
UNSPSC
12352200
Hazard Statement
H315, H319, H335
Target
Toll-like Receptor (TLR)
Type
Biochemical Assay Reagents
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zymosan-a.html
Solubility
DMSO : 1.94 mg/mL (ultrasonic; warming; adjust pH to 4 with HCl; heat to 60°C) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
[ZymosanA]
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tubulin beta 3 / TUBB3 (Neuronal & Stem Cell Marker) (TUBB3/3732), CF568 conjugate, 0.1mg/mL
Cadherin 17 / LI Cadherin (Liver-Intestine Marker) (CDH17/2617), CF405S conjugate, 0.1mg/mL
Cytokeratin 5/8 (C-50), CF405S conjugate, 0.1mg/mL
